Right doc, so what's the issue? They can go for Standard 4. The market cap will be about $2B with the IPO, The total assets need to be appraised and better be more than $80M, so the stockholders equity will be way above $55M and Joe said in the 10/8/2020 conf call he is looking at $5 share price. So the only thing slowing this down is Joe getting the appraisal done. I can't imagine a firm that does this type of appraisal with big boys would need so much time to analyze the value of our breast cancer AE37 trial and covid potential, unless Joe hasn't released the covid results to them either. Or again, maybe it was a money thing since we had no revenue with all the businesses Joe bought.